Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spyropoulos

Showing results (621-630 of 640) with videos related to

Pageof 64
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countriesStefano Barco, Luca Valerio, Andrea Gallo, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 13, 2026
A Non-Interventional, Multicenter, Observational Study to Provide Real World Evidence on the Diagnosis of Chronic Coronary Syndrome In Patients With Diabetes Mellitus In Greece - The CONTACT STUDYAnastasia Thanopoulou, Anastasios Tentolouris, Charalambos Vlachopoulos, et al.
Journal of Lipid Research|April 24, 2021
Endothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegenerationLarry D Spears, Sangeeta Adak, Guifang Dong, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Thrombosis and Haemostasis|December 7, 2017
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
International Angiology : a Journal of the International Union of Angiology|January 10, 2014
Prevention and treatment of venous thromboembolism--International Consensus StatementA N Nicolaides, J Fareed, A K Kakkar, et al.
JAMA Internal Medicine|August 6, 2019
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantJames D Douketis, Alex C Spyropoulos, Joanne Duncan, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
American Heart Journal|September 4, 2021
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE TrialEduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, et al.
Pageof 64

Showing results (621-630 of 640) with videos related to

Sort By:
Pageof 64
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countriesStefano Barco, Luca Valerio, Andrea Gallo, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 13, 2026
A Non-Interventional, Multicenter, Observational Study to Provide Real World Evidence on the Diagnosis of Chronic Coronary Syndrome In Patients With Diabetes Mellitus In Greece - The CONTACT STUDYAnastasia Thanopoulou, Anastasios Tentolouris, Charalambos Vlachopoulos, et al.
Journal of Lipid Research|April 24, 2021
Endothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegenerationLarry D Spears, Sangeeta Adak, Guifang Dong, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Thrombosis and Haemostasis|December 7, 2017
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and RationaleJames D Douketis, Alex C Spyropoulos, Julia M Anderson, et al.
International Angiology : a Journal of the International Union of Angiology|January 10, 2014
Prevention and treatment of venous thromboembolism--International Consensus StatementA N Nicolaides, J Fareed, A K Kakkar, et al.
JAMA Internal Medicine|August 6, 2019
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantJames D Douketis, Alex C Spyropoulos, Joanne Duncan, et al.
Journal of Thrombosis and Haemostasis : JTH|September 5, 2020
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.
American Heart Journal|September 4, 2021
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE TrialEduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, et al.
Pageof 64